Skip to main content
. 2021 Dec 28;8(1):e000813. doi: 10.1136/bmjgast-2021-000813

Table 3.

Incidence of adverse events

MedDRA preferred term (n=11)
Patients reporting ≥1 adverse event 9 (82%)
Patients reporting ≥1 serious adverse event 1 (9%)
Abdominal pain 4 (36%)
Headache 3 (27%)
Flatulence 2 (18%)
Orthostatic hypotension 1 (9%)
Anorexia 1 (9%)
Sepsis 1 (9%)
Pharyngitis streptococcal 1 (9%)
Faeces discoloured 1 (9%)
Hypotension 1 (9%)
Faeces hard 1 (9%)
Diarrhoea 1 (9%)
Ear pain 1 (9%)
Chills 1 (9%)
Fatigue 1 (9%)
Acne 1 (9%)
Pruritus 1 (9%)
Eye haemorrhage 1 (9%)
Rash 1 (9%)
Frequent bowel movements 1 (9%)
Polyuria 1 (9%)